UroMems was founded in 2011 and focuses on designing, developing and commercializing active implantable medical devices. The company is based at the heart of the French Alps, in the city of Grenoble, representing one of the most dynamic French area in the Medtechs industry. UroMems is highly innovative and focuses on clearly identified clinical unmet needs, not only for their prevalence but also for their negative impact on patient’s quality of life. Significative investments have been made in the development of the UroMems’ first product through 2 financing rounds, for a total amount of € 28 million. This includes the participation of Wellington Partners, Munich, Germany, Bpifrance via FABS Fund, Cita Investissement, Supernova Invest, b-to-v Partners AG, Hil-Invent, Financière Arbevel and the founders.